Commentary

Mpox Surge in Africa: The Urgent Need for Better Community Engagement Strategies to Combat the Historical Context of Mistrust

The recent surge in Mpox cases in Africa, with over 18,737 cases and 541 deaths in 2024, highlights a growing public health crisis. The emergence of the virulent Clade 1b strain in the Democratic Republic of Congo (DRC) and its recognition as a sexually transmitted infection has prompted swift action from health organizations. Despite Mpox being endemic in parts of Central, East, and West Africa, socio-economic disparities, inadequate healthcare, and weak disease surveillance drive the outbreak. Effective community engagement, hindered by mistrust in public health interventions, is critical for containment. Countries like the DRC and Nigeria face public cooperation challenges due to previous campaign failures and limited local involvement. This article advocates for locally adapted health initiatives, involving community leaders and health workers, using culturally sensitive messaging and local languages while leveraging both mass and social media to enhance outreach. These efforts can increase vaccine uptake, improve prevention, and help curb the spread of Mpox in Africa.

Keywords

Mpox, Community Engagement, Vaccine Uptake, Outbreak Response, Africa

n Introduction

The increasing spread of Mpox cases in Africa has raised alarm bells across the continent. Africa has recorded 18,737 cases (suspected and confirmed) and 541 deaths from Mpox in 2024 alone — about 126 percent of the total number of cases reported in 2023 . Mpox has a case fatality rate of 3.9%, particularly among children younger than 15 years who make up to 60% of confirmed cases . This sharp rise, coupled with detection of the more lethal Clade 1b in the Democratic Republic of Congo (DRC) and neighboring regions, has raised significant alarm. Mpox was previously thought to be a zoonotic disease endemic in parts of Central, East and West Africa; however, the global outbreak has shown that the disease is changing in various ways .

In response, both the World Health Organization (WHO) and the Africa Centres for Disease Control and Prevention (Africa CDC) promptly declared Mpox a Public Health Emergency of International Concern (PHEIC) and a Public Health Emergency of Continental Concern (PHEC) in August 2024. The recent emergence of a new clade and rise in Mpox incidence reflects a complex interplay of socio-economic factors, inadequate healthcare infrastructure, weak disease surveillance, and inadequate community engagement .

Every individual case of Mpox comes from within the community, most of the time through Primary Healthcare Centres de Santé . Hence, effective community engagement and surveillance is perhaps one of the most important ways to checkmate the spread of Mpox. This article focuses on strategies to improve community engagement of cases, ensuring prompt identification, treatment, and acceptance of preventive measures — including vaccination. We examine the historical context of mistrust, highlight successful community engagement programs from both high-income countries and low- and middle-income countries, and provide actionable recommendations.

Historical Context of Mistrust in African Communities

The Democratic Republic of Congo (DRC) exemplifies the longstanding challenges faced by public health interventions in gaining community trust. This mistrust is rooted in the perceived ineffectiveness of past health campaigns, inadequate local involvement, and historical exploitation by external organizations . During Ebola outbreaks, many communities expressed skepticism toward foreign health workers, suspecting research priorities overshadowed genuine local health concerns . Similar sentiments have emerged regarding Mpox, as public health campaigns are often viewed as top-down approaches that neglect local knowledge and practices.

As revealed by a qualitative Twitter-based study , one of the significant challenges with Mpox vaccination is the mistrust and stigma associated with Mpox, which has been inaccurately labeled as a disease primarily affecting the LGBTQ+ community. This stigmatization has led to widespread hesitancy. The stigma and misinformation not only deter vulnerable populations from seeking vaccination but also complicate the efforts of public health agencies to communicate effectively.

The 2017 Mpox response further reflected ongoing mistrust. Despite WHO involvement, many individuals remained reluctant to accept vaccinations. Local narratives suggested health workers focused more on data collection than on providing genuine care, leading to widespread refusal of vaccination . The lasting effects of colonialism and medical experimentation significantly influence people's beliefs and their willingness to adopt recommended behaviors .

In Nigeria, misinformation spread rapidly through social networks during the 2017 outbreak, and local leaders were not sufficiently engaged. Reports noted that rumors circulated on social media that individuals in army uniforms were entering schools to administer monkeypox virus injections as part of a population-reduction scheme . More recent misinformation includes Mpox being described as a side effect of the SARS-CoV-2 vaccine, or as a biological weapon .

During the 2022 Mpox outbreak in Nigeria, a study by our team found that only 58% of respondents were aware of Mpox, and only 15.5% had ever heard of the Mpox vaccine — reflecting an urgent need for better community engagement strategies in Africa's most populous country.

Community Engagement as the Cornerstone for Effective Public Health Strategy

During infectious disease outbreaks, community engagement campaigns that are culturally sensitive, evidence-based, and tailored to local contexts are necessities. A rapid review on community engagement during communicable epidemics identified six crucial groups: local leaders, community and faith-based organizations, various community groups, health system committees, individual community members, and key stakeholders. Engaging communities fosters trust, which is crucial for encouraging early reporting of cases, adherence to preventive measures, and acceptance of vaccination.

Nigeria, the first country in Africa to receive the Jynneos Mpox vaccines, received 10,000 doses and was set to begin Mpox vaccination on 8 October 2024 . Community members must be informed not only about evidence-based information on Mpox transmission and symptoms, but also about the importance and safety of vaccination as availability to high-risk groups is scaled up in Africa.

Lessons from Successful Community Engagement Strategies

Some high-income countries have demonstrated the effectiveness of community engagement strategies in managing the 2022 Mpox outbreak. The "Get the Facts" campaign in the United States utilized social media, community events, and partnerships with trusted community leaders, resulting in increased awareness and vaccine uptake . The US campaign also deployed targeted outreach collaborating with LGBTQ+ organizations to disseminate information and promote vaccination . The CDC participated in approximately 50 community engagement campaigns with affected groups to develop Mpox-related communications.

Similarly, the United Kingdom implemented a comprehensive public health campaign emphasizing clear messaging about Mpox transmission and prevention. The NHS engaged local communities through workshops and informational sessions, significantly improving vaccination rates and reducing stigma .

Recommendations for Tailoring Community Engagement in LMICs

Although high-income countries have effectively implemented community engagement strategies, low- and middle-income countries (LMICs) encounter distinct challenges requiring customized approaches. In Nigeria, public health campaigns must consider cultural beliefs, a highly diverse environment with over 250 languages, local practices, and the socio-economic realities of communities. The following strategies have proven effective:

  • Involving Community Health Workers and Local Leaders
    Including local leaders and influencers in public health messaging leverages existing community structures and enhances credibility and reach. This approach proved successful in Nigeria's polio campaigns, where religious leaders in the northern region were actively involved .
  • Culturally Sensitive Messaging
    Campaigns must be designed with cultural relevance in mind. In Sierra Leone during the Ebola outbreak, health officials worked with traditional healers to incorporate local practices into prevention messages, leading to increased community acceptance of public health measures .
  • Local Language Utilization
    Materials should be translated into local languages to improve comprehension and accessibility. SRHIN's #STOPCOVID project disseminated COVID-19 messages into over 100 languages, reaching millions of people across Africa and internationally . Educational materials in local languages should also be printed and displayed in PHCs and local health centers.
  • Community Workshops and Education on Vaccination
    Public health campaigns should emphasize the safety and efficacy of the Mpox vaccine, directly addressing concerns and misconceptions. Community-led dialogues, such as those organized by the Dean Initiative in Rivers State, Nigeria, helped address prevailing myths surrounding COVID-19 vaccination .
  • Community Involvement in Planning and Mobilization
    Engaging local leaders and stakeholders in the planning and implementation of health initiatives fosters trust and enhances participation. During the Ebola response in Sierra Leone, community-led action plans resulted in an increase in safe burials and cases referred within 24 hours of symptom onset .
  • Incorporating Feedback Mechanisms
    Establishing channels for community feedback helps public health authorities adapt strategies in real-time. In Kenya, a mobile phone-based feedback system for maternal health services led to a 36.6% increase in the facilities' ability to identify risk factors for adverse healthcare outcomes .
  • Leveraging Mass Media, Social Media, and Information Technology
    Utilizing SMS alerts and social media platforms to provide timely updates on Mpox symptoms, prevention, and vaccination can significantly enhance community awareness. SRHIN's community work on the Canada-Africa Mpox Partnership project reached over 57,000 people on X/Twitter in August 2024 alone, indicating the massive potential of social media in making health information accessible .
Conclusion

The surge of Mpox in Africa underscores the urgent need for improved community engagement strategies. The historical context of mistrust in the DRC, Nigeria, and Cameroon has profound implications for current and future Mpox campaigns. Community members often view public health interventions with suspicion, leading to low participation rates and ineffective disease control measures. This skepticism is shaped by a history of inadequate responses to health crises and a lack of transparency from health authorities.

To combat this mistrust, public health initiatives must prioritize community engagement and cultural sensitivity. By learning from successful initiatives in high-income countries and adapting them to the African context, public health authorities can enhance awareness, acceptance, and adherence to preventive measures. Efforts should focus on building trust through local partnerships, involving community leaders in health campaigns, and ensuring that interventions are tailored to the specific needs and beliefs of the populations served. As Mpox vaccines roll out across Africa, prioritizing community engagement will be essential in mitigating the spread of this disease and protecting public health.

Ethical Approval

Not applicable. This paper does not involve human participants, animal subjects, or primary data collection.

Funding Information

The authors received no specific funding for the preparation of this paper.

Author Contributions

Peter Seyi Aremu contributed to conceptualization and original drafting. Mary Akinwola supported in writing. Madonna Badom contributed to critical revisions. Matthew Olawoyin supported manuscript review and editing. Oluwasegun Isaac Oguntoye contributed to final revisions and editing.

Declaration of Competing Interests

The authors declare that they have no competing interests.

Acknowledgements

The authors would like to thank colleagues and peers who provided general support and feedback during the development of this manuscript.

  1. Africa Centre for Disease Control and Prevention (Africa CDC). Mpox Situation in Africa. Addis Ababa: Africa CDC; 2024. Available from: https://africacdc.org/disease-outbreak/mpox-situation-in-africa/. [Accessed 26 August 2024].

  2. Ndembi N, Folayan MO, Ngongo N, Ntoumi F, Ogoina D, El Rabbat M, Okwo-Bele JM, Kaseya J. Mpox outbreaks in Africa constitute a public health emergency of continental security. Lancet Global Health. 2024 Aug 20. https://doi.org/10.1016/s2214-109x(24)00363-2

  3. Ogoina D, Damon I, Nakoune E. Clinical review of human mpox. Clinical Microbiology and Infection. 2023 Sep 12. https://doi.org/10.1016/j.cmi.2023.09.004

  4. Mercy K, Tibebu B, Fallah M, Faria NR, Ndembi N, Tebeje YK. Mpox continues to spread in Africa and threatens global health security. Nature Medicine. 2024;30(5):1225–6. https://doi.org/10.1038/s41591-024-02862-6

  5. Musuka G, Moyo E, Tungwarara N, Mhango M, Pierre G, Saramba E, Iradukunda PG, Dzinamarira T. A critical review of mpox outbreaks, risk factors, and prevention efforts in Africa. IJID Regions. 2024 Jul 6:100402. https://doi.org/1₀.₁₀₁₆/j.ijregi.₂₀₂₄.₁₀₀₄₀₂

  6. World Health Organization, Regional Office for Africa. Rallying to defeat mpox in Africa. https://www.afro.who.int/photo-story/rallying-defeat-mpox-nigeria. Published 2024. [Accessed 26 August 2024].

  7. Smith MJ, Upshur RE. Ebola and learning lessons from moral failures: who cares about ethics? Public Health Ethics. 2015;8(3):305–18. https://doi.org/10.1093/phe/phv028

  8. Muzembo BA, Ntontolo NP, Ngatu NR, Khatiwada J, Suzuki T, Wada K, Kitahara K, Ikeda S, Miyoshi SI. Misconceptions and rumors about Ebola Virus disease in Sub-Saharan Africa: a systematic review. Int J Environ Res Public Health. 2022;19(8):4714. https://doi.org/10.3390/ijerph19084714

  9. Collier K, Klein EK, Sevalie S, et al. Ebola Virus Disease Sensitization: Community-Driven Efforts in Sierra Leone. Journal of Community Health. 2023;49(1):108–116. https://doi.org/10.1007/s10900-023-01265-x

  10. Trapido J. Ebola: public trust, intermediaries, and rumour in the DR Congo. Lancet Infectious Diseases. 2019;19(5):457–8. https://doi.org/10.1016/s1473-3099(19)30044-1

  11. Rajkhowa P, Dsouza VS, Kharel R, Cauvery K, Mallya BR, Raksha DS, et al. Factors Influencing Monkeypox Vaccination: A Cue to Policy Implementation. J Epidemiol Glob Health. 2023;13(2):226–238. https://doi.org/10.1007/s44197-023-00100-9

  12. Hrynick T, Muzalia G, James M. Key considerations: Risk Communication and community engagement for Mpox Vaccination in Eastern DRC. Institute of Development Studies and Partner Organizations. 2024. https://doi.org/10.19088/SSHAP.2024.024

  13. Mosby I, Swidrovich J. Medical experimentation and the roots of COVID-19 vaccine hesitancy among Indigenous Peoples in Canada. CMAJ. 2021;193(11):E381–3. https://doi.org/10.1503/cmaj.210112

  14. Tilley H. COVID-19 across Africa: colonial hangovers, racial hierarchies, and medical histories. Journal of West African History. 2020;6:155–179.

  15. Okanume OB. The Monkey pox virus and the inherent danger in rumour-mongering: focus on Nigeria print media reportage of the crisis. N Media Mass Commun. 2017;64:54–64.

  16. Bakare D, Salako J, Sogbesan A, Olojede OE, Bakare AA. Assessment of the Level of Awareness, Knowledge, and Risk Perception of Community Members About Mpox Infection in Nigeria. Annals of Ibadan Postgraduate Medicine. 2024;22(1):76.

  17. Olufadewa II, Adesina MA, Oladele RI, et al. Mpox epidemic in Nigeria: Knowledge, awareness, and willingness of Nigerians to receive the Mpox vaccine. Pan African Medical Journal. 2024. Under Peer Review.

  18. Gilmore B, Ndejjo R, Tchetchia A, de Claro V, Mago E, Lopes C, Bhattacharyya S. Community engagement for COVID-19 prevention and control: a rapid evidence synthesis. BMJ Global Health. 2020;5(10):e003188. https://doi.org/10.1136/bmjgh-2020-003188

  19. Anyaogu I. Nigeria to start mpox vaccination on October 8. Reuters. 2024. Available from: https://www.reuters.com/world/africa/nigeria-start-mpox-vaccination-october-8-2024-08-31/. [Accessed 25 July 2024].

  20. Delaney KP. Strategies adopted by gay, bisexual, and other men who have sex with men to prevent monkeypox virus transmission, United States, August 2022. MMWR Morb Mortal Wkly Rep. 2022;71. https://doi.org/10.15585/mmwr.mm7135e1

  21. McQuiston JH, Braden CR, Bowen MD, et al. The CDC Domestic Mpox Response — United States, 2022–2023. MMWR Morb Mortal Wkly Rep. 2023;72(20):547–552. https://doi.org/10.15585/mmwr.mm7220a2

  22. GILEAD. Gilead Sciences and a Coalition of LGBTQ+ and Human Rights-Focused Organizations Mobilize to Address Monkeypox Public Health Emergency. Gilead.com. 2022. Available from: gilead.com. Accessed 26 August 2024.

  23. UK Health Security Agency. UK Strategy for Mpox Control. Available from: gov.uk. [Accessed 4 September 2024].

  24. Birukila G, Babale SM, Epstein H, et al. Reducing resistance to polio immunisation with free health camps and Bluetooth messaging. Global Public Health. 2016;12(1):19–30. https://doi.org/10.1080/17441692.2016.1152283

  25. Nasir SG, Aliyu G, Ya'u I, Gadanya M, Mohammad M, Zubair M, El-Kamary SS. From intense rejection to advocacy: How Muslim clerics were engaged in a polio eradication initiative in Northern Nigeria. PLoS Medicine. 2014;11(8):e1001687. https://doi.org/10.1371/journal.pmed.1001687

  26. Polio Global Eradication Initiative. Religious leaders fuelling demand for polio vaccines and health services in Nigeria. Available from: polioeradication.org. [Accessed 26 August 2024].

  27. Taylor S, Khan M, Muhammad A, Akpala O, van Strien M, Morry C, Feek W, Ogden E. Understanding vaccine hesitancy in polio eradication in northern Nigeria. Vaccine. 2017;35(47):6438–43. https://doi.org/10.1016/j.vaccine.2017.09.075

  28. James PB, Wardle J, Steel A, Adams J, Bah AJ, Sevalie S. Traditional and complementary medicine use among Ebola survivors in Sierra Leone. BMC Complementary Medicine and Therapies. 2020;20:1. https://doi.org/10.1186/s12906-020-02931-6

  29. Slum and Rural Health Initiative Network (SRHIN). Stop COVID-19 Campaign. https://srhin.org/our-project/covid-19-project/. [Accessed 26 August 2024].

  30. Martin S, Rassi C, Antonio V, Graham K, Leitão J, King R, Jive E. Evaluating the feasibility and acceptability of a community dialogue intervention for schistosomiasis prevention in Mozambique. PLoS One. 2021;16(8):e0255647. https://doi.org/10.1371/journal.pone.0255647

  31. Dean Initiative. Transforming Borikiri's Attitude towards Government Approved Vaccines: A Community's Journey towards Vaccine Equity and Health Accountability. Published 13 October 2023. [Accessed 26 August 2024].

  32. Jalloh MF, Sengeh P, James N, et al. Integrated digital system for community engagement during the 2014–2016 Ebola outbreak in Sierra Leone. BMJ Global Health. 2020;5(12):e003936. https://doi.org/10.1136/bmjgh-2020-003936

  33. Liyayi BN. Effects of Timed Phone Call Surveillance Versus Routine Care on Postpartum Care, Identification of Risk Factors and Adverse Maternal and Neonatal Outcomes at Kenyatta National Hospital. University of Nairobi. 2021. http://erepository.uonbi.ac.ke/handle/11295/160839

  34. Amanyi-Enegela JA, Badaki JA, Alege GO, Okunade F, Kumbur J, Ishaya R, et al. Community Feedback on Mass Medicines Administration for Neglected Tropical Diseases in Federal Capital Territory, Abuja, Nigeria. Tropical Medicine and Infectious Disease. 2024;9(6):126. https://doi.org/10.3390/tropicalmed9060126

About the Authors

Peter Seyi Aremu

Affiliation: Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria

Mary Akinwola

Affiliation: Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria

mary.akinwola@srhin.org

Madonna Badom

Affiliation: Faculty of Education, University of Calabar, Calabar, Nigeria

Matthew Olawoyin

Affiliation: Department of Medicine and Surgery, University of Ilorin, Ilorin, Nigeria

Oluwasegun Isaac Oguntoye

Affiliation: Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria

Corresponding Author

Mary Akinwola
Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
Email: mary.akinwola@srhin.org